(Q38029729)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Targeting STAT3 in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author

Trevelyan R Menheniott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Louise M. Judd

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Andrew S Giraud

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

26 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

889-901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22834702%20AND%20SRC:MED&resulttype=core&format=json

STAT signaling in head and neck cancer

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori, cell proliferation, and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Carcinogenesis of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

The effect of gender on Helicobacter felis‐mediated gastritis, epithelial cell proliferation, and apoptosis in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Gastrin is an essential cofactor for helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Cytokine signalling via gp130 in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inefficient chronic activation of parietal cells in Ae2a,b(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

No potassium, no acid: K+ channels and gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Emerging role of IL-23/IL-17 axis in H pylori-associated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

The role of interleukin-17 in the Helicobacter pylori induced infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

T(H)17 cells in tumour immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Oncogenic mechanisms of the Helicobacter pylori CagA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

SagA of CagA in Helicobacter pylori pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori and atrophic gastritis: importance of the cagA status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Grb2 is a key mediator of helicobacter pylori CagA protein activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Expression of seven gastric cancer-associated genes and its relevance for Wnt, NF-kappaB and Stat3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Small molecule inhibitors of Stat3 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Functional characterization of W147A: a high-affinity interleukin-11 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

New generation contraceptives: interleukin 11 family cytokines as non-steroidal contraceptive targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Novel high-throughput screening system for identifying STAT3-SH2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Multiple roles of STAT3 in cardiovascular inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

STAT3 and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Function of mitochondrial Stat3 in cellular respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.709238